2025 annual financial data

Silo Pharma 2025 Financial results

Direct answer

Revenue was 72,102 USD.

Operating income was -4,280,662 USD and net income was -4,227,698 USD.
Operating cash flow was -4,661,339 USD.

Get free Silo Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
72,102 USD
Operating income
-4,280,662 USD
Net income
-4,227,698 USD
Operating cash flow
-4,661,339 USD